China Newborn Screening Market Size & Outlook, 2023-2030
China newborn screening market, 2018-2030 (US$M)
Related Markets
China newborn screening market highlights
- The China newborn screening market generated a revenue of USD 75.6 million in 2023 and is expected to reach USD 120.5 million by 2030.
- The China market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
Newborn screening market data book summary
| Market revenue in 2023 | USD 75.6 million |
| Market revenue in 2030 | USD 120.5 million |
| Growth rate | 6.9% (CAGR from 2023 to 2030) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, China accounted for 9.5% of the global newborn screening market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Thailand newborn screening market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 75.5 million by 2030.
Tandem mass spectrometry was the largest segment with a revenue share of 24.6% in 2023. Horizon Databook has segmented the China newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
Presently, less than 50% babies born undergo newborn screening every year in China. The newborn population is the highest in China and currently newborn screening is significant only in eastern China.
However, supportive government initiatives to create awareness are expected to boost the procedure volume over the forecast period. Owing to the economy development and growing disposable income, China is expected to be the fastest growing market for newborn screening market in Asian region.
China has 20% of the global population, but healthcare expenditure per capita is comparatively less. Growing total healthcare expenditure as a part of GDP and foreign direct investment policies by current government are expected to be helpful in the market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China newborn screening market size, by technology, 2018-2030 (US$M)
China Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
